https://scholars.lib.ntu.edu.tw/handle/123456789/161418
Title: | First-in-human phase I study of EGF816, a third generation, mutant-selective EGFR tyrosine kinase inhibitor, in advanced non-small cell lung cancer (NSCLC) harboring T790M. | Authors: | Tan, Daniel Shao-Weng Seto, Takashi Leighl, Natasha B. Riely, Gregory J. Sequist, Lecia V. Felip, Enriqueta Wolf, Juergen Yang, James Chih-Hsin Matushansky, Igor Yu, Xiaolu Schmitz, Shu-Fang Hsu Cui, Xiaoming Kim, Dong-Wan |
Issue Date: | 2015 | Journal Volume: | 33 | Journal Issue: | 15 | Start page/Pages: | - | Source: | J. Clin. Oncol. | URI: | http://ntur.lib.ntu.edu.tw//handle/246246/279801 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.